About BRIGHT MINDS
BRIGHT MINDS is a company based in Canada founded in 2017.. BRIGHT MINDS has raised $1.04 million across 8 funding rounds from investors including Janus Henderson Investors, RA Capital and Perceptive Advisors. BRIGHT MINDS offers products and services including BMB-101 and Neuropsychiatry Programs.
- Headquarter Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bright Minds Biosciences Inc.
-
Annual Revenue
$0 (USD)0as on Sep 30, 2024
-
Net Profit
$-1.95 M (USD)61.99as on Sep 30, 2024
-
EBITDA
$-1.9 M (USD)62.43as on Sep 30, 2024
-
Total Equity Funding
$1.04 M (USD)
in 8 rounds
-
Latest Funding Round
$35 M (USD), Post-IPO
Oct 18, 2024
-
Investors
Janus Henderson Investors
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BRIGHT MINDS
BRIGHT MINDS is a publicly listed company on the CSE with ticker symbol DRUG in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BRIGHT MINDS
BRIGHT MINDS offers a comprehensive portfolio of products and services, including BMB-101 and Neuropsychiatry Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
BMB-101 is developed as a highly selective agonist for epilepsy treatment, where serotonin regulation is utilized to address central nervous system disorders
Neuropsychiatry programs are designed to target mental health conditions through the creation of selective 5-HT2A and 5-HT2C agonists, focusing on brain health innovation
Unlock access to complete
Unlock access to complete
Funding Insights of BRIGHT MINDS
BRIGHT MINDS has successfully raised a total of $1.04M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $35 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $35.0M
-
First Round
First Round
(23 Jul 2020)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Post-IPO - BRIGHT MINDS | Valuation |
investors |
|
| Dec, 2023 | Amount | Post-IPO - BRIGHT MINDS | Valuation |
investors |
|
| May, 2022 | Amount | Post-IPO - BRIGHT MINDS | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BRIGHT MINDS
BRIGHT MINDS has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Janus Henderson Investors, RA Capital and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BRIGHT MINDS
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BRIGHT MINDS
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bright Minds Comparisons
Competitors of BRIGHT MINDS
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bright Minds
Frequently Asked Questions about BRIGHT MINDS
When was BRIGHT MINDS founded?
BRIGHT MINDS was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is BRIGHT MINDS located?
BRIGHT MINDS is headquartered in Canada.
Is BRIGHT MINDS a funded company?
BRIGHT MINDS is a funded company, having raised a total of $1.04M across 8 funding rounds to date. The company's 1st funding round was a Post-IPO of $142.43K, raised on Jul 23, 2020.
What does BRIGHT MINDS do?
BRIGHT MINDS was founded in 2017 in Canada. Operations are conducted within the pharmaceutical sector, where drugs targeting mental health disorders are manufactured. Focus is placed on producing medications for conditions such as anxiety, depression, and other related issues. The company maintains its online presence through the domain brightmindsbio.com, with activities centered in the Canadian market. Research and development efforts support the creation of these therapeutic products.
What products or services does BRIGHT MINDS offer?
BRIGHT MINDS offers BMB-101 and Neuropsychiatry Programs.
Is BRIGHT MINDS publicly traded?
Yes, BRIGHT MINDS is publicly traded on CSE under the ticker symbol DRUG.
Who are BRIGHT MINDS's investors?
BRIGHT MINDS has 7 investors. Key investors include Janus Henderson Investors, RA Capital, Perceptive Advisors, Cormorant, and Vivo Capital.
What is BRIGHT MINDS's ticker symbol?
The ticker symbol of BRIGHT MINDS is DRUG on CSE.